Results 291 to 300 of about 114,465,275 (302)

Combined treatments with Hadrontherapy – in vitro tests and preclinical approach

2018
G. Russo, P. Pisciotta, V. Marchese, F. P. Cammarata, L. Minafra, G. I. Forte, V. Bravatà, G. A. P. Cirrone, A. L. Fallacara, L. Maccari, F. Torrisi, G. Calabrese, R. Parenti, M. Botta, G. Cuttone   +14 more
openaire   +1 more source

Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive models

Nature Reviews Drug Discovery, 2019
Richard Weaver, B Kevin Park, Ursula Klingmüller   +2 more
exaly  

In vitro 3D blood/lymph-vascularized human stromal tissues for preclinical assays of cancer metastasis

Biomaterials, 2018
Akihiro Nishiguchi, Hiroshi Shimoda, Hiroshi Nishihara   +2 more
exaly  

A Narrative Review of Preclinical In Vitro Studies Investigating microRNAs in Myocarditis

Current Issues in Molecular Biology
Małgorzata Wrzosek, Grzegorz Procyk, Olga Grodzka   +2 more
exaly  

A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-d]Pyrimidine Dual Src/P-Glycoprotein Inhibitor

Cancers, 2019
Tijana Stanković, Ana Podolski-Renić, Riccardo Torelli   +2 more
exaly  

Preclinical Models of Pediatric Brain Tumors—Forging Ahead

Bioengineering, 2018
Vidyā Gopalakrishnan, Tara Dobson
exaly  

Beyond the hype and toward application: liver complex in vitro models in preclinical drug safety

Expert Opinion on Drug Metabolism and Toxicology
Sushma Jadalannagari, Lorna Ewart
exaly  

The Temozolomide–Doxorubicin paradox in Glioblastoma in vitro–in silico preclinical drug-screening

Scientific Reports
Eleftheria Tzamali, Mariam-Eleni Oraiopoulou, Vangelis Sakkalis   +2 more
exaly  

In vitro preclinical lead optimisation technologies (PLOTs) in pharmaceutical development

Toxicology Letters, 2002
exaly  

In VitroMetabolism in Preclinical Drug Development

Miia Turpeinen, Olavi Pelkonen, Ari Tolonen   +2 more
exaly